Pediatric infectious diseases are caused by microorganisms and affect children. They range from common respiratory infections to more severe conditions. In low- and middle-income countries, these diseases contribute significantly to child morbidity and mortality. The emergence of antimicrobial resistance (AMR) has made managing these diseases more challenging. Inappropriate antibiotic use has led to the development and spread of drug-resistant bacteria.
The World Health Organization (WHO) developed the Global Action Plan on AMR in 2015 to combat this issue. The plan promotes responsible antimicrobial use, better surveillance, infection prevention, and research for new treatments. For pediatric infectious diseases, the plan highlights the importance of accurate diagnosis, proper treatment guidelines, and tailored antibiotic prescriptions based on local resistance patterns. It also emphasizes preventive measures like vaccination, improved sanitation, hygiene practices, and infection control in healthcare settings.
Addressing pediatric infectious diseases and AMR requires collaboration among healthcare providers, policymakers, researchers, and communities.
To combat antimicrobial resistance (AMR) in pediatric infectious diseases, key actions include strengthening antimicrobial stewardship programs, enhancing surveillance systems, promoting research and development for new treatments, improving infection prevention and control, and increasing public awareness and education. Robust stewardship programs should focus on judicious antibiotic use. Surveillance systems monitor resistance patterns and antimicrobial consumption. Research should prioritize safe and effective antibiotics for children and explore non-antibiotic interventions. Infection prevention measures reduce transmission and healthcare-associated infections. Public awareness campaigns educate on appropriate antibiotic use. By implementing these actions collaboratively, stakeholders can effectively manage pediatric infectious diseases and address AMR while preserving the effectiveness of antimicrobial agents.
The research topic explores the intersection of pediatric infectious diseases and the Global Action Plan on Antimicrobial Resistance (AMR). It covers epidemiology, antimicrobial resistance patterns, stewardship, surveillance, prevention strategies, non-antibiotic interventions, and socio-cultural factors.
Original research, reviews, perspectives, and opinions are welcome, emphasizing successful interventions, best practices, and policy implications. Manuscripts should provide evidence-based insights, innovative approaches, and practical recommendations to tackle AMR in pediatric infectious diseases.
Pediatric infectious diseases are caused by microorganisms and affect children. They range from common respiratory infections to more severe conditions. In low- and middle-income countries, these diseases contribute significantly to child morbidity and mortality. The emergence of antimicrobial resistance (AMR) has made managing these diseases more challenging. Inappropriate antibiotic use has led to the development and spread of drug-resistant bacteria.
The World Health Organization (WHO) developed the Global Action Plan on AMR in 2015 to combat this issue. The plan promotes responsible antimicrobial use, better surveillance, infection prevention, and research for new treatments. For pediatric infectious diseases, the plan highlights the importance of accurate diagnosis, proper treatment guidelines, and tailored antibiotic prescriptions based on local resistance patterns. It also emphasizes preventive measures like vaccination, improved sanitation, hygiene practices, and infection control in healthcare settings.
Addressing pediatric infectious diseases and AMR requires collaboration among healthcare providers, policymakers, researchers, and communities.
To combat antimicrobial resistance (AMR) in pediatric infectious diseases, key actions include strengthening antimicrobial stewardship programs, enhancing surveillance systems, promoting research and development for new treatments, improving infection prevention and control, and increasing public awareness and education. Robust stewardship programs should focus on judicious antibiotic use. Surveillance systems monitor resistance patterns and antimicrobial consumption. Research should prioritize safe and effective antibiotics for children and explore non-antibiotic interventions. Infection prevention measures reduce transmission and healthcare-associated infections. Public awareness campaigns educate on appropriate antibiotic use. By implementing these actions collaboratively, stakeholders can effectively manage pediatric infectious diseases and address AMR while preserving the effectiveness of antimicrobial agents.
The research topic explores the intersection of pediatric infectious diseases and the Global Action Plan on Antimicrobial Resistance (AMR). It covers epidemiology, antimicrobial resistance patterns, stewardship, surveillance, prevention strategies, non-antibiotic interventions, and socio-cultural factors.
Original research, reviews, perspectives, and opinions are welcome, emphasizing successful interventions, best practices, and policy implications. Manuscripts should provide evidence-based insights, innovative approaches, and practical recommendations to tackle AMR in pediatric infectious diseases.
